Parent and Child Acceptable Symptom State in Juvenile Idiopathic Arthritis

REFERENCES

1. 1.↵
   1. Ravelli A,
   2. Martini A

   . Juvenile idiopathic arthritis. Lancet 2007;369:767–78.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Hashkes PJ,
   2. Laxer RM

   . Medical treatment of juvenile idiopathic arthritis. JAMA 2005;294:1671–84.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Hayward K,
   2. Wallace CA

   . Recent developments in anti-rheumatic drugs in pediatrics: Treatment of juvenile idiopathic arthritis. Arthritis Res Ther 2009;11:216.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Martini A,
   2. Lovell DJ

   . Juvenile idiopathic arthritis: State of the art and future perspectives. Ann Rheum Dis 2010;69:1260–3.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Scott C,
   2. Meiorin S,
   3. Filocamo G,
   4. Lanni S,
   5. Valle M,
   6. Martinoli C,
   7. et al.

   A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. Clin Exp Rheumatol 2010;28:774–81.

   OpenUrlPubMed
6. 6.↵
   1. Ruperto N,
   2. Giannini EH,
   3. Pistorio A,
   4. Brunner HI,
   5. Martini A,
   6. Lovell DJ

   . Is it time to move to active comparator trials in juvenile idiopathic arthritis ? A review of current study designs. Arthritis Rheum 2010;62:3131–9.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Wallace CA,
   2. Ruperto N,
   3. Giannini EH

   . Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290–4.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Wallace CA,
   2. Huang B,
   3. Bandeira M,
   4. Ravelli A,
   5. Giannini EH

   . Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005;52:3554–62.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Ravelli A,
   2. Martini A

   . Remission in juvenile idiopathic arthritis. Clin Exp Rheumatol 2006;24 (Suppl 43):S105–10.

   OpenUrlPubMed
10. 10.↵
    1. Wells G,
    2. Boers M,
    3. Shea B,
    4. Anderson J,
    5. Felson D,
    6. Johnson K,
    7. et al.

    MCID/low disease activity state workshop: Low disease activity state in rheumatoid arthritis. J Rheumatol 2003;30:1110–1.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Tubach F,
    2. Wells GA,
    3. Ravaud P,
    4. Dougados M

    . Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: Methodological issues. J Rheumatol 2005;32:2025–9.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Magni-Manzoni S,
    2. Ruperto N,
    3. Pistorio A,
    4. Sala E,
    5. Solari N,
    6. Palmisani E,
    7. et al.

    Development and validation of a preliminary definition of minimal disease activity in juvenile idiopathic arthritis. Arthritis Rheum 2008;59:1120–7.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Dougados M

    . It’s good to feel better but it’s better to feel good. J Rheumatol 2005;32:1–2.

    OpenUrlFREE Full Text
14. 14.↵
    1. Ravelli A,
    2. Viola S,
    3. Migliavacca D,
    4. Pistorio A,
    5. Ruperto N,
    6. Martini A

    . Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis. Rheumatology 2001;40:914–9.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Garcia-Munitis P,
    2. Bandeira M,
    3. Pistorio A,
    4. Magni-Manzoni S,
    5. Ruperto N,
    6. Schivo A,
    7. et al.

    Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. Arthritis Rheum 2006;55:177–83.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Sztajnbok F,
    2. Coronel-Martinez DL,
    3. Diaz-Maldonado A,
    4. Novarini C,
    5. Pistorio A,
    6. Viola S,
    7. et al.

    Discordance between physician’s and parent’s global assessments in juvenile idiopathic arthritis. Rheumatology 2007;46:141–5.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Consolaro A,
    2. Vitale R,
    3. Pistorio A,
    4. Lattanzi B,
    5. Ruperto N,
    6. Malattia C,
    7. et al.

    Physicians’ and parents’ ratings of inactive disease are frequently discordant in juvenile idiopathic arthritis. J Rheumatol 2007;34:1773–6.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Kvien TK,
    2. Heiberg T,
    3. Hagen KB

    . Minimal clinically important improvement/difference (MCII/MCID) and patients acceptable symptom state (PASS): What do these concepts mean? Ann Rheum Dis 2007;66 (Suppl III):iii40–1.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Maksymowych WP,
    2. Richardson R,
    3. Mallon C,
    4. van der Heijde D,
    5. Boonen A

    . Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 2007;57:133–9.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Heiberg T,
    2. Kvien TK,
    3. Mowinckel P,
    4. Aletaha D,
    5. Smolen JS,
    6. Hagen KB

    . Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:967–71.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Petty RE,
    2. Southwood TR,
    3. Manners P,
    4. Baum J,
    5. Glass DN,
    6. Goldenberg J,
    7. et al.

    International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J Rheumatol 2004;31:390–2.

    OpenUrlFREE Full Text
22. 22.↵
    1. Filocamo G,
    2. Consolaro A,
    3. Schiappapietra B,
    4. Dalprà S,
    5. Lattanzi B,
    6. Magni-Manzoni S,
    7. et al.

    A new approach to clinical care of juvenile idiopathic arthritis: The Juvenile Arthritis Multidimensional Assessment Report. J Rheumatol 2011;38:938–53.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Filocamo G,
    2. Sztajnbok F,
    3. Cespedes-Cruz A,
    4. Magni-Manzoni S,
    5. Pistorio A,
    6. Viola S,
    7. et al.

    Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis. Arthritis Rheum 2007;57:913–20.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Filocamo G,
    2. Schiappapietra B,
    3. Bertamino M,
    4. Pistorio A,
    5. Ruperto N,
    6. Magni-Manzoni S,
    7. et al.

    A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: Initial validation in juvenile idiopathic arthritis. Rheumatology 2010;49:1272–80.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Filocamo G,
    2. Davì S,
    3. Pistorio A,
    4. Bertamino M,
    5. Ruperto N,
    6. Lattanzi B,
    7. et al.

    Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis. J Rheumatol 2010;37:1534–41.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Tubach F,
    2. Ravaud P,
    3. Beaton D,
    4. Boers M,
    5. Bombardier C,
    6. Felson DT,
    7. et al.

    Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. J Rheumatol 2007;34:1188–93.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Ravelli A,
    2. Viola S,
    3. Ruperto N,
    4. Corsi B,
    5. Ballardini G,
    6. Martini A

    . Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis 1997;56:197–200.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Brunner HI,
    2. Giannini EH

    . Health-related quality of life in children with rheumatic diseases. Curr Opin Rheumatol 2003;15:602–12.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Duffy CM

    . Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: Clinical science for the pediatrician. Pediatr Clin North Am 2005;52:359–72.

    OpenUrlCrossRefPubMed